| Bonus Resources.txt | 102.4 B | ||
| Get Bonus Downloads Here.url | 204.8 B | ||
| ~Get Your Files Here ! | |||
| 1 - Introduction | |||
| 1 - Introduction to the Course Mastering CMC for Biologics – From IND to BLA (Description).html | 1.9 KB | ||
| 1 - Introduction to the Course Mastering CMC for Biologics – From IND to BLA.mp4 | 17 MB | ||
| 10 - CTD Module-3 Quality (CMC) Writing Tips & Strategy (Stage by Stage IND to BLA) | |||
| 11 - Breakdown On Binding & Non-Binding Regulatory Conditions CTD Module 3 Quality | |||
| 12 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices) | |||
| 13 - Biosimilars CMC Regulatory Strategy & Analytical Similarity | |||
| 14 - Strategy A stepwise approach to CMC planning for BLA | |||
| 15 - Real CMC Lessons – From IND to BLA | |||
| 1 - Practice Test – Mastering CMC for Biologics.html | 79.7 KB | ||
| 2 - Introduction of Biologics | |||
| 2 - Introduction of Biologics (Description).html | 1.4 KB | ||
| 2 - Introduction of Biologics.mp4 | 120 MB | ||
| 3 - Monoclonal Antibodies - The Model Biologics | |||
| 3 - Monoclonal Antibodies - The Model Biologics (Description).html | 2 KB | ||
| 3 - Monoclonal Antibodies - The Model Biologics.mp4 | 106.8 MB | ||
| 4 - Manufacturing Process of Monoclonal Antibodies | |||
| 4 - Manufacturing Process of Monoclonal Antibodies (Description).html | 1.4 KB | ||
| 4 - Manufacturing Process of Monoclonal Antibodies.mp4 | 148 MB | ||
| 5 - Cell Banking in Biologics | |||
| 6 - Biologics Characterization | |||
| 10 - Biologics Characterization Part-2.mp4 | 111.5 MB | ||
| 11 - Biologics Characterization Part-3.mp4 | 129.8 MB | ||
| 7 - Integrated Control Strategy & Comparability | |||
| 12 - Integrated Control Strategy & Comparability-Part 1 (Description).html | 1.9 KB | ||
| 12 - Integrated Control Strategy & Comparability-Part 1.mp4 | 103.8 MB | ||
| 13 - Integrated Control Strategy & Comparability-Part 2 Setting of Specifications.mp4 | 65.4 MB | ||
| 14 - Integrated Control Strategy & Comparability-Part 3 Comparability Study.mp4 | 117.5 MB | ||
| 8 - Stability Studies of Biologics | |||
| 15 - Stability Studies of Biologics-Part 1 (Description).html | 1.7 KB | ||
| 15 - Stability Studies of Biologics-Part 1.mp4 | 141 MB | ||
| 16 - Stability Studies of Biologics-Part 2 Extractable and Leachable (E&L).mp4 | 26.6 MB | ||
| 17 - Stability Studies of Biologics-Part 3 Shipping Qualification.mp4 | 50 MB | ||
| 9 - CTD Mapping – Modules 1 to 5 | |||
| 18 - CTD Mapping - Module 1 to 5 (Description).html | 1.4 KB | ||
| 18 - CTD Mapping - Module 1 to 5.mp4 | 34.1 MB | ||
| 9 - Biologics Characterization Part-1 (Description).html | 1.9 KB | ||
| 9 - Biologics Characterization Part-1.mp4 | 104.4 MB | ||
| 6 - Cell Banking in Biologics-Part 1 (Description).html | 1.8 KB | ||
| 6 - Cell Banking in Biologics-Part 1.mp4 | 59.1 MB | ||
| 7 - Cell Banking in Biologics-Part 2.mp4 | 82.2 MB | ||
| 8 - Cell Banking in Biologics-Part 3.mp4 | 105 MB | ||
| 5 - Quality by Design (QbD) and Process Validation (Description).html | 1.5 KB | ||
| 5 - Quality by Design (QbD) and Process Validation.mp4 | 211.2 MB | ||
| 28 - Apply real-world CMC lessons and regulatory insights to BLA (Description).html | 1.6 KB | ||
| 28 - Apply real-world CMC lessons and regulatory insights to BLA.mp4 | 120.7 MB | ||
| 27 - Strategy-Planning For BLA (Description).html | 1.3 KB | ||
| 27 - Strategy-Planning For BLA.mp4 | 79.5 MB | ||
| 26 - Biosimilars (Description).html | 1.7 KB | ||
| 26 - Biosimilars.mp4 | 69.8 MB | ||
| 21 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 1 (Description).html | 1.8 KB | ||
| 21 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 1.mp4 | 459.4 MB | ||
| 22 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 2.mp4 | 81.7 MB | ||
| 23 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 3.mp4 | 95.5 MB | ||
| 24 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 4.mp4 | 109.9 MB | ||
| 25 - Deep Dive into CTD MODULE 3 – QUALITY (3.2.S, 3.2.P & Appendices)-Part 5.mp4 | 83.4 MB | ||
| 20 - Established Conditions (PCs) Module 3 Quality (Description).html | 1.6 KB | ||
| 20 - Established Conditions (PCs) Module 3 Quality.mp4 | 102 MB | ||
| 20 - SECTION_U-10_Breakdown on Binding & Non-Binding Regulatory Conditions.pptx | 11.1 MB | ||
| 19 - CTD Module 3 Writing Tips (Description).html | 1.6 KB | ||
| 19 - CTD Module 3 Writing Tips.mp4 | 97.4 MB |
Mastering CMC for Biologics: From IND to BLA
https://WebToolTip.com
Published 7/2026
MP4 | Video: h264, 1920x1080 | Audio: AAC, 44.1 KHz, 2 Ch
Language: English | Duration: 6h 17m | Size: 2.97 GB
Learn Biologics CMC, CTD Module 3, regulatory strategy, comparability, and global IND, BLA, MAA, and JNDA submissions.
What you'll learn
Develop complete CMC regulatory strategies for biologics from IND/IMPD through BLA, MAA, and JNDA submissions.
Author and critically review CTD Module 3 (Quality) for biologics, including drug substance, drug product).
Design scientifically justified control strategies, comparability plans, process validation, and lifecycle management approaches.
Prepare regulatory briefing packages, respond to health authority questions, and provide practical CMC consulting using real-world examples.
Gain a comprehensive understanding of types of biologics , development, integrated control strategy, process changes, comparability, and lifecycle management.
Learn CMC and regulatory requirements for biosimilars, including analytical similarity, comparability, and global regulatory expectations.
Develop the knowledge and confidence to work in Biologics CMC and Regulatory Affairs across development, submission, and lifecycle management.
Requirements
A basic understanding of pharmaceuticals, biotechnology, life sciences, chemistry, pharmacy, or a related scientific field is helpful but not mandatory.
No prior regulatory affairs experience is required; all fundamental concepts are explained before advancing to complex topics.
Willingness to learn biologics CMC, regulatory strategy, and global submission requirements.
A computer or tablet for viewing lectures and downloading course resources.
Pharma Students or professional with experience in Regulatory Affairs, Quality, Manufacturing, Analytical Development, Process Development, Validation, or Project Management will gain advanced practical insights.
All Comments